• Schwartz on Teva Pharmaceuticals v. Sandoz: Inside the Case

    by  • October 15, 2014 • Faculty Commentary, Multimedia • 0 Comments

    [Reposted from ISCOTUSnow]


    On October 15, 2014, the Supreme Court heard oral argument in Teva Pharmaceuticals v. Sandoz, a pharmaceutical patent case that could clarify critical issues of claim construction in patent litigation as well as the relative power of trial courts and appellate courts in such matters. Professor David Schwartz discusses the background of the case and the central issue: What is the proper standard of review that the appellate court should use to review claim constructions of a patent done by trial courts?

    About

    The purpose of the C-K Faculty Blog is to provide a forum that brings together all the rich intellectual contributions of the Chicago-Kent faculty and to encourage respectful and scholarly dialogue within the extended Chicago-Kent community, including faculty, students, alumni and colleagues at other law schools and universities. For questions or more information, contact the C-K Faculty Blog Editor by e-mail at facultyscholarship@kentlaw.iit.edu.

    Leave a Reply

    Your email address will not be published. Required fields are marked *